Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 2/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27444582 | 0.81 | TSHR (0.37) | CA2CA12CA1CA9L3MBTL1 | |
| SCHEMBL5797600 | 0.80 | CA2 (0.33) | CA2 | |
| SCHEMBL3212068 | 0.77 | CA2 (0.46) | CA2CA12CA1CA9KMT2A | |
| SCHEMBL3211322 | 0.74 | CA12 (0.45) | CA2CA12CA1CA9MEN1 | |
| SCHEMBL3215200 | 0.73 | CA12 (0.41) | CA2CA12CA1CA9HPGD | |
| SCHEMBL4901107 | 0.73 | CA2 (0.42) | CA2CA12CA1CA9KMT2A | |
| SCHEMBL14100165 | 0.73 | SMN1; SMN2 (0.35) | KEAP1MEN1KMT2ASMN1; SMN2L3MBTL1 | |
| SCHEMBL3216663 | 0.71 | ALDH1A1 (0.45) | CA2CA12CA1CA9L3MBTL1 | |
| SCHEMBL6150867 | 0.70 | CA2 (0.33) | CA2CA12CA1CA9 | |
| SCHEMBL6733242 | 0.70 | CA2 (0.33) | CA2CA12CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100475040-C | Aminocarbonyl-substituted thienylsulfonylamino (thio) carbonyltriazolin (thi) ones, process for their preparation and their use | BAYER CROPSCIENCE AG (DE) | 2009-04-08 | — | — | CN | disclosed |
| US-20080171662-A1 | Aminocarbonyl-Substituted Thiensulfonylamino(Thio)Carbonyl-Triazolin(Ethi)Ones, Processes For Their Preparation And Their Use | BAYER CROPSCIENCE AG (DE) | 2008-07-17 | — | — | US | disclosed |
| US-20080171662-A1 | Aminocarbonyl-Substituted Thiensulfonylamino(Thio)Carbonyl-Triazolin(Ethi)Ones, Processes For Their Preparation And Their Use | BAYER CROPSCIENCE AG (DE) | 2008-07-17 | — | — | US | disclosed |
| US-20080171662-A1 | Aminocarbonyl-Substituted Thiensulfonylamino(Thio)Carbonyl-Triazolin(Ethi)Ones, Processes For Their Preparation And Their Use | BAYER CROPSCIENCE AG (DE) | 2008-07-17 | — | — | US | disclosed |
| CN-1984564-A | Aminocarbonyl-substituted thienylsulfonylamino (thio) carbonyltriazolin (thi) ones, process for their preparation and their use | BAYER CROPSCIENCE AG (DE) | 2007-06-20 | — | — | CN | disclosed |
| EP-1776012-A1 | AMINOCARBONYL-SUBSTITUTED THIENSULPHONYLAMINO (THIO) CARBONYLTRIAZOLIN (THI) ONES METHODS FOR PRODUCTION AND USE THEREOF | Bayer CropScience Aktiengesellschaft (DE) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006012983-A1 | AMINOCARBONYL-SUBSTITUTED THIENSULPHONYLAMINO (THIO) CARBONYLTRIAZOLIN (THI) ONES METHODS FOR PRODUCTION AND USE THEREOF | BAYER CROPSCIENCE AG (DE) | 2006-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171662-A1 | Aminocarbonyl-Substituted Thiensulfonylamino(Thio)Carbonyl-Triazolin(Ethi)Ones, Processes For Their Preparation And Their Use | TST, SULT1E1, CBR3 | CA2 1518/4885CA12 4441/4885CA1 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.